Terheyden, Patrick
University of Lübeck
2 papers on CoChatORCID 0000-0002-5894-1677
Most cited papers
- Verified
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Kaufman, H. L., Russell, J., Hamid, O., Bhatia, S., Terheyden, P., D'Angelo, S. P., Shih, K. C., Lebbé, C., Linette, G. P., Milella, M., et al. (2016) · The Lancet Oncology
Polyomavirus and related diseasesNonmelanoma Skin Cancer Studies
Cited by 1,236
- Verified
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Kaufman, H. L., Russell, J. S., Hamid, O., Bhatia, S., Terheyden, P., D’Angelo, S. P., Shih, K. C., Lebbé, C., Milella, M., Brownell, I., et al. (2018) · Journal for ImmunoTherapy of Cancer
Polyomavirus and related diseasesNonmelanoma Skin Cancer Studies
Cited by 334
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free